| 31 |
Conversion of CAR binder to TCE format |
2026.10.01 |
Accepting |
| 30 |
SEC-HPLC 문의 |
2026.09.29 |
Complete |
|
└ Re : SEC-HPLC 문의 |
2026.09.29 |
Accepting |
| 28 |
CHO cell 기반 recombinant IgG 생산 가능 여부 문의 |
2026.04.30 |
Complete |
|
└ Re : CHO cell 기반 recombinant IgG 생산 가능 여부 문의 |
2026.05.06 |
Accepting |
| 26 |
possible investment |
2026.03.18 |
Complete |
|
└ Re : possible investment |
2026.03.18 |
Accepting |
| 24 |
eCNTFR and eCNTFR-Fc recombinant protein |
2026.02.09 |
Complete |
|
└ Re : eCNTFR and eCNTFR-Fc recombinant protein |
2026.02.13 |
Accepting |
| 22 |
eCNTFR and eCNTFR-Fc recombinant protein |
2026.02.07 |
Complete |
|
└ Re : eCNTFR and eCNTFR-Fc recombinant protein |
2026.02.09 |
Accepting |
| 20 |
Proposal for Joint MOTIE (KIAT-GITCC) Project on Next-Gen ADC Formulation (Y-Biologics × Purdue University) |
2025.12.13 |
Complete |
|
└ Re : Proposal for Joint MOTIE (KIAT-GITCC) Project on Next-Gen ADC Formulation (Y-Biologics × Purdue University) |
2025.12.15 |
Accepting |
| 18 |
항체 견적 문의 |
2025.11.24 |
Complete |
|
└ Re : 항체 견적 문의 |
2025.11.26 |
Accepting |
| 16 |
Nanobody library screening 문의 |
2025.05.28 |
Complete |
|
└ Re : Nanobody library screening 문의 |
2025.06.05 |
Accepting |
| 14 |
Company Introduction and Development Pipeline Overview |
2025.03.11 |
Complete |
|
└ Re : Company Introduction and Development Pipeline Overview |
2025.03.17 |
Accepting |
| 12 |
recombinant protein 관련 문의드립니다. |
2024.01.18 |
Complete |
